Nanoencapsulation for drug delivery by Kumari, Avnesh et al.
EXCLI Journal 2014;13:265-286 – ISSN 1611-2156 
Received: January 31, 2014, accepted: February 19, 2014, published: March 20, 2014 
 
 
265 
Review article: 
NANOENCAPSULATION FOR DRUG DELIVERY 
 
Avnesh Kumari1, Rubbel Singla1, 2, Anika Guliani1, Sudesh Kumar Yadav1, 2,* 
 
1 Biotechnology Division, CSIR – Institute of Himalayan Bioresource Technology,  
Palampur-176061 (H.P.), India 
2 Academy of Scientific and Innovative Research, New Delhi, India 
 
* Corresponding author: E-mail: skyt@rediffmail.com;sudeshkumar@ihbt.res.in 
 
ABSTRACT 
Nanoencapsulation of drug/small molecules in nanocarriers (NCs) is a very promising ap-
proach for development of nanomedicine. Modern drug encapsulation methods allow efficient 
loading of drug molecules inside the NCs thereby reducing systemic toxicity associated with 
drugs. Targeting of NCs can enhance the accumulation of nanonencapsulated drug at the dis-
eased site. This article focussed on the synthesis methods, drug loading, drug release mecha-
nism and cellular response of nanoencapsulated drugs on liposomes, micelles, carbon nano-
tubes, dendrimers, and magnetic NCs. Also the uses of these various NCs have been high-
lighted in the field of nanotechnology. 
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INTRODUCTION 
Nanoencapsulation of therapeutic 
agents increases their efficacy, specificity 
and targeting ability (Soppimath et al., 
2000). Nanocarriers (NCs) protect their 
payload from premature degradation in the 
biological environment, enhance bioavaila-
bility, and prolong presence in blood and 
cellular uptake (Kumari et al., 2010a, b). 
Many methods are reported in literature for 
the synthesis of NCs (Galindo-Rodriguez et 
al., 2004). Synthesis methods are chosen 
depending upon the chemical structure of 
therapeutic agent, type of application 
(Alonso, 2004) and time of retention inside 
the body (Peer et al., 2007). Different sized 
NCs can be synthesized by using different 
matrices (Dobrovolskaia and McNeil, 
2007). Size and size distribution of NCs are 
important to determine their cellular uptake 
and penetration across biological barriers 
(Kumari and Yadav, 2011). Size and sur-
face chemistry of NCs determine their in 
vivo performance (Suri et al., 2007). Drug 
release mechanisms are equally important 
from the drug-NC-formulation due to pro-
posed application in drug delivery (Yoo et 
al., 1999). Release mechanism can also be 
modulated depending upon the nature of 
therapeutic agent and type of NCs (Yadav 
et al., 2013). 
Conventional NCs are cleared from the 
body by mononuclear phagocytic system 
(MPS). MPS recognises NCs as foreign 
particles and rapidly removes from the sys-
temic circulation (Storm et al., 1995). How-
ever, if prolonged presence in blood is re-
quired than surface of NCs are easily modi-
fied in order to prevent phagocytosis 
(Storm et al., 1995). Surface of NCs are al-
so modified to increase their targeting abil-
ity and delivery of drug at target site. Sur-
face modification of NCs is conducted ei-
ther by tagging ligand (Weissleder et al., 
2005) or hydrophilic polymers (Gref et al., 
1995) on their surface. Surface charge is 
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another important parameter which affects 
cellular response of NCs (Verma and Stel-
lacci, 2010). NCs with cationic charge are 
efficiently taken up by negatively charged 
cell membranes as compared to neutral or 
positively charged ones (Muñoz Javier et 
al., 2006).  
Smart designing of NCs with respect to 
target site and route of administration will 
solve the problems faced by therapeutic 
agents. In the successive headings, we have 
discussed the effect of nanoencapsulation of 
various drugs on liposomes, micelles, car-
bon nanotubes, dendrimers, and magnetic 
NCs. This article further focused on the ef-
fect of various therapeutic agents upon en-
capsulation in different NCs, and their im-
pacts on controlled release, surface charac-
teristics and cellular response.  
 
LIPOSOMES 
Liposomes are spherical vesicles with a 
phospholipid bilayer and are extensively 
used in drug and gene delivery. Liposomes 
protect therapeutic agents from degradation, 
deliver it at target site and are versatile 
enough to allow tagging of small molecules 
for targeted delivery (Felnerova et al., 
2004). Liposomes are synthesized by using 
cationic lipids, anionic lipids or neutral li-
pids depending upon the mode of use and 
drug to be encapsulated. Liposomes solely 
composed of charged lipids may not be 
suitable for drug delivery because they do 
not form charged vesicles that are capable 
of entrapping drug molecules (Shi et al., 
2002).  
 
Synthesis of liposomes 
Many methods have been reported in 
the literature for the synthesis of liposomes. 
These are discussed here briefly. 
Polycarbonate membrane extrusion method 
In this method lipid dissolved in chloro-
form is dried into thin film. The dried lipid 
film is then added to buffer solution con-
taining the drug molecule of interest. The 
lipid solution is sonicated, freeze dried and 
subjected to extrusion 10 times through 
100 nm pore size polycarbonate membrane 
to form liposomes. Uniform sized lipo-
somes are formed by this method (Shi et al., 
2002). 
High pressure homogenisation 
Homogenous blend of lipids is prepared 
by dissolving them in organic solvents, 
shock freezing in liquid nitrogen and freeze 
drying the blend. Freeze dried lipid is then 
dissolved in PBS and subjected to high 
pressure homogenisation to form lipo-
somes. 
Reversed phase evaporation method 
Lipids dissolved in mixture of chloro-
form and methanol is dried into thin film. 
Dried lipid film is then dissolved in diethyl 
ether aqueous phase and sonicated to form 
homogenous oil in water (o/w) emulsion. 
The organic solvent is then evaporated un-
der vaccum (Gareipy et al., 2002).  
Sonication method 
Briefly, lipids dissolved in chloroform 
are dried into thin film and then suspended 
in tris-HCl buffer. The multilammelar vesi-
cles produced are then sonicated in bath 
type sonicator to form unilammelar vesicles 
(Nakagawa et al., 2007). 
Lipid film hydration sonication extrusion 
method 
Lipid solution in organic solvent is 
dried into thin film. The dried lipid film is 
then hydrated in ammonium sulfate, soni-
cated in bath sonicator and sequentially ex-
truded through polycarbonate membrane of 
desired pore size (Xiong et al., 2005).  
 
Encapsulation of different types of drugs 
Drugs are directly added to the lipid so-
lution for the formation of drug loaded lipo-
somes. Encapsulation efficiency is calculat-
ed indirectly by measuring the amount of 
drug in the supernatant by UV-Vis spectro-
photometer and HPLC. Different types of 
drugs have been encapsulated on liposomes 
to increase their efficacy and specificity.  
Anticancer molecule methotrexate was 
encapsulated in inner aqueous phase of lip-
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osomes. More than 90 % of methotrexate 
was retained within liposome during stor-
age of 24 hours at 4 ºC (Konigsberg et al., 
1998).  Another drug doxorubicin has been 
used in the treatment of cancers of bladder, 
stomach, ovaries, lung, thyroid and others. 
But its use has been found to be associated 
with toxicities like gastrointestinal myelo-
suppression, alopecia and mucositis. This 
was overcome by encapsulation of doxoru-
bicin on liposomes that has increased reten-
tion time and reduced toxicity of doxorubi-
cin (Kale et al., 2012). In another study 
doxorubicin was loaded on sterically stabi-
lised liposomes. Administration of doxoru-
bicin loaded in RGD grafted sterically sta-
bilised liposomes has significantly retarded 
tumour growth (Xiong et al., 2005). N-
butyldeoxynojirimycin is used for inhibi-
tion of tyrosinase in melanoma cells. N-
butyldeoxynojirimycin was successfully 
loaded on pH sensitive liposomes made up 
of dioleoylphosphatidylethanolamine and 
cholesteryl hemisuccinate. pH sensitive lip-
osomes have reduced the dosage required 
for tyrosinase inhibition by a factor of 1000 
(Costin et al., 2002).  
Ciprofloxacin was also successfully 
loaded on liposomes with 45 % loading ef-
ficiency. Release rate of encapsulated 
ciprofloxacin was modulated by addition of 
cysteine to the dithiobenzyl urethane link-
age between the lipid and the PEG in lipo-
somes (Karathanasis et al., 2005). The anti-
fungal agent clotrimazole was successfully 
encapsulated in untradeformable liposomes. 
Liposome encapsulated clotrimazole has 
exhibited greater skin penetration than free 
clotrimazole (Maheshwari et al., 2012). 
Tretinoin has been used in treatment of var-
ious skin diseases like psoriasis, acne, epi-
dermotropic and T-cell lymphomas. But the 
use of tretinoin as drug is limited due to low 
water solubility, skin irritation, and high in-
stability in presence of air, light and heat. 
Therefore, tretinoin was encapsulated on 
liposomes. Negatively charged liposomes 
have strongly improved tretinoin retention 
in skin (Sinico et al., 2005). 
Surface modification of liposomes 
A major drawback of liposomes is their 
unspecific interaction with macromolecules 
and cellular surfaces resulting in their short 
half life. Conventional liposomes are rapid-
ly cleared by macrophages of mononuclear 
system (MPS), particularly Kupffer cells in 
the liver and spleen macrophages. This 
drawback can be overcome by coating the 
surface of liposomes with hydrophilic pol-
ymers like PEG. Coating of PEG on the 
surface of liposomes creates a steric barrier 
(Kale et al., 2012). Targeting of liposomes 
to specific sites can be achieved by tagging 
ligands on the surface of liposomes. Mono-
clonal antibodies, ligands and peptide se-
quences can be attached to the surface of 
liposomes for targeted delivery (Felnerova 
et al., 2004). 
 
Drug loading and release from liposomes 
The drug is located in the interior part 
of liposomes. The efficient encapsulation of 
drug is essential requirement for the suc-
cessful application of liposomes in drug de-
livery. Many encapsulation techniques are 
reported in literature which varies accord-
ing to the type of drug and the type of lipo-
somal formulation. Drug loading in lipo-
somes can be achieved by passive and ac-
tive loading. In passive loading dried lipid 
film is rehydrated in the presence of drug to 
give rise to drug loaded liposomes (Colle-
tier et al., 2002). In active loading drug is 
loaded on readymade liposomes via con-
centration or pH transmembrane gradient 
(Abraham et al., 2004). 
Release mechanism can be modulated 
by effective combination of functional head 
groups, lipid chains and linker groups in 
membrane components for controlled re-
lease of encapsulated material under specif-
ic conditions. Release mechanism in lipo-
somes can occur by four mechanisms. First 
mechanism involves pH dependent neutral-
isation of charged functional groups of 
membrane components (Ellens et al., 1984). 
Second mechanism involves pH dependent 
hydrolysis of non charged components in-
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tegrated in membranes (Guo and Szoka, 
2001). Third mechanism involves thiolysis 
of disulfide bonds present in membrane li-
pids. Thiolysis occurs by change of redox 
potential of surrounding environment, for 
example on moving from extracellular sur-
face to cytoplasm (Zhang et al., 2004). 
Fourth mechanism uses temperature for re-
lease of drug. This mechanism is used by 
thermosensitive liposomes for release of 
drug (Lindner et al., 2004; Needham and 
Dewhirst, 2001). 
 
Cellular response of liposomes 
Cellular uptake of liposomes follows 
endocytic pathway. An important strategy 
is to attach a ligand on the surface of lipo-
somes which will stick to its receptors on 
cell surface or in the extracellular matrix of 
the cell. Liposomes tagged with ligands un-
dergo cellular uptake by receptor mediated 
endocytosis (Shao et al., 2006). In one 
study adhesion of plain, PEGylated lipo-
somes and concanvalin grafted liposomes to 
model membranes was investigated. Plain 
liposomes exhibited unspecific adhesion to 
lipid membranes. The degree of membrane 
interaction was increased when plain lipo-
somes were grafted with lectin (Bakowsky 
et al., 2008). N-acetylglucosamine-
conjugated liposomes have exhibited great-
er interaction with cardiomyocytes in vitro 
(Aso et al., 2007). Human recombinant in-
terleukin-2 grafted liposomes showed re-
ceptor mediated endocytosis in murine 
CTLL-2 T-cell line (Konigsberg et al., 
1998).  
 
POLYMERIC MICELLES 
Polymeric micelles have attracted atten-
tion as a nanosized drug carrier due to small 
size and high structural stability (Yamamo-
to et al., 2007). Polymeric micelles are clas-
sified according to type of intermolecular 
forces driving the core segment from aque-
ous media. Three types of micelles are am-
phiphilic micelles formed by hydrophobic 
interactions, polyion complex micelles 
formed by electrostatic interactions and mi-
celles stemming from metal ion complexa-
tion (Gaucher et al., 2005). Hydrophobic 
block of the copolymers form the core of 
the micelles. Many polymers that have been 
used as hydrophobic segment in polymeric 
micelles are poly(propylene glycol) (PPO, 
Pluronics®) (Marin et al., 2002), poly(as-
partic acid) with chemically conjugated 
doxorubicin (PAsp(DOX) (Yokoyama et 
al.1998), poly(β-benzyl-L-aspartate) (PBLA) 
(Kwon et al., 1995), and polyesters such as 
poly(lactic acid) (PLA) (Liggins and Burt, 
2002), poly(ε-caprolactone) (PCL) (Allen et 
al., 2000), and poly (trimethylenecarbonate) 
(PTMC) (Zhang et al., 2006). Core forming 
materials of the micelles have been found to 
affect stability, drug loading capacity and 
drug release profile. Micelles are formed 
when concentration of block copolymer is 
increased above a certain level known as 
critical micellar concentration (Rijcken et 
al., 2007). 
 
Synthesis of micelles 
Polymeric micelles are prepared by 
many methods. Choice of synthesis method 
depends on the nature of drug, and type of 
polymer used. Some of the commonly used 
techniques are as follow. 
Solvent extraction technique 
Solvent extraction technique is used for 
the preparation of polymeric micelles for 
high drug loading, good stability and ex-
tended release. In this method, preformed 
polymers are dissolved in acetone and add-
ed dropwise to double distilled water under 
stirring. Organic solvent is then removed 
after purging with dry nitrogen (Forrest et 
al., 2006a). 
Dialysis method 
Polymers dissolved in water miscible 
organic solvents are dialysed against water. 
Slow removal of organic solvent leads to 
micelle formation (Gaucher et al., 2005).  
Solution casting method 
Polymers dissolved in organic solvent 
are dried into thin film. The thin film is 
then rehydrated with heated aqueous sol-
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vent to form micelles (Gaucher et al., 
2005). 
 
Encapsulation of different types of drugs 
Many drugs have been encapsulated on 
micelles to enhance their solubility, and 
therapeutic activity. Doxorubicin was en-
capsulated on pluronic micelles. Doxorubi-
cin encapsulation in micelles has reduced 
the systemic uptake of doxorubicin to nor-
mal cells by 2 fold as compared to free drug 
(Marin et al., 2002). Paclitaxel was success-
fully encapsulated in micelles made up of 
amphiphilic block copolymers composed of 
methoxy poly(ethylene glycol) (MPEG) 
and poly(ε-caprolactone) (PCL). Paclitaxel 
encapsulated in amphiphilic block copoly-
mers have exhibited greater cytotoxicity to 
cancer cells documenting the significance 
of micelles (Park et al., 2005). Camptothe-
cin was successfully incorporated into pol-
ymeric micelles formed from poly(ethylene 
glycol)-poly(benzyl aspartate) block copol-
ymers. Camptothecin loaded in polymeric 
micelles have significantly inhibited the 
tumour growth after single in vivo injection. 
Also, camptothecin loaded in polymeric 
micelles showed greater retention in blood 
and higher accumulation in tumors as com-
pared to free camptothecin (Kawano et al., 
2006). Oxaliplatin was loaded on 
poly(ethylene glycol)-β-poly(glutamic acid) 
polymeric micelles. Oxaliplatin loaded in 
polymeric micelles showed enhanced anti-
tumor activity (Cabral et al., 2007). β-
lapachone is plant derived anticancer drug 
whose cytotoxic effect is significantly en-
hanced by NAD(P)H: quinone oxidoreduc-
tase 1. β-lapachone was encapsulated on 
PEG-PLA micelles. β-lapachone encapsu-
lated in PEG-PLA micelles also showed 
slow and sustained release (Blanco et al., 
2007). 
Amphotericin B is a potent antibiotic 
used for fungal infections. Amphotericin B 
was successfully loaded on polymeric mi-
celles of poly(ethylene oxide)-block–
poly(N-hexyl-L-aspartamide). Amphoteri-
cin loaded in polymeric micelles showed 
sustained release (Adams et al., 2003). Gel-
danamycin was loaded on polymeric mi-
celles of poly(ethylene glycol)-b-poly(ε-
caprolactone) (PEG-b-PCL). Such loading 
of geldanamycin in polymeric micelles has 
significantly improved the aqueous solubili-
ty and efficacy (Forrest et al., 2006b). An-
driamycin was loaded successfully on 
poly(L-histidine) poly(L-lactic acid) poly-
meric micelles. Andriamycin showed pH 
dependent release from polymeric micelles 
(Lee et al., 2003). Cyclosporin A is a potent 
immunosuppressive agent used primarily to 
reduce the incidence of graft rejection in re-
cipients of transplanted organs. Cyclosporin 
A was loaded on methoxy poly(ethylene 
oxide)-β-poly(ε-caprolactone) micelles. 
Polymeric micelles showed slow and sus-
tained release of cyclosporin A (Aliabadi et 
al., 2005). Rapamycin is lipophilic macro-
lide antibiotic with anti-fungal, immuno-
suppressive, and anti-tumor activities. Ra-
pamycin was loaded on PEG-PCL polymer-
ic micelles. Rapamycin showed slow and 
sustained release from PEG-PCL micelles 
(Forrest et al., 2006a). 
Plasmid DNA containing bacterial LacZ 
gene was incorporated into poly(dimethyl-
aminoethyl methacrylate (poly(butylmetha-
crylate) polymeric micelles. Polymeric mi-
celles loaded with DNA were able to trans-
fect cells without causing any toxicity 
(Funhoff et al., 2005). 
 
Surface modification of micelles 
Surface of micelles is modified for in-
creasing circulation time in blood. Hydro-
philic polymers are most commonly used 
polymer for surface modification of mi-
celles. Among all, PEG is the most com-
monly used hydrophilic polymer for in-
creasing persistence inside the blood. PEG 
forms a brush like corona projecting out 
from the surface of polymeric micelles 
(Gaucher et al., 2005). Hydrophilic PEG 
corona is important in preventing opsonin 
adsorption and clearance by mononuclear 
phagocytic system (Kwon, 2003). Stealth 
properties and half life of acetaldehyde 
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functionalised PEG-b-PDLLA micelles 
were enhanced by anchoring anionic pep-
tidyl ligand on the surface of micelles 
which imparted negative charge to the mi-
celles (Yamamoto et al., 2001). 
Targeting ability can be imparted to mi-
celles by attaching ligands, receptors or an-
tibodies to the hydrophilic segment so that 
they interact with membrane receptors. 
Targeted micelles have exhibited greater 
cellular uptake and improved efficacy than 
unmodified counterparts (Gaucher et al., 
2005). 
 
Drug loading and release from micelles 
Drugs can be incorporated into poly-
meric micelles by physical entrapment or 
chemical conjugation (Gaucher et al., 
2005). Also, the drug can be loaded into the 
core of micelles with the help of organic 
solvents through o/w emulsion, dialysis and 
solid dispersion. Release of drug from pol-
ymeric micelles is affected by many factors 
such as the length of the core forming pol-
ymer segment, affinity between the drug 
and the core, and the amount of the loaded 
drug (Huh et al., 2005). The release of 
physically adsorbed drug from polymeric 
micelles is controlled by diffusion of drug 
from micellar core and the partition coeffi-
cient of the drug over micellar core and the 
aqueous phase. 
 
Cellular response of micelles 
Folate conjugated micelles showed 
greater uptake in MCF-7 cells through in-
teraction with overexpressed folate recep-
tors on the surface of cancer cells (Park et 
al., 2005). In another study folate conjugat-
ed poly (L-histidine)–poly (L-lactic acid) 
micelles were more effective in killing can-
cer cells (Lee et al., 2003). Poly(dimethyl-
aminoethyl methacrylate), poly(butylmetha-
crylate) polymeric micelles were able to 
transfect COS-7 and OVCAR-3 cells with 
minor toxicity (Funhoff et al., 2005). Poly-
meric micelles of polyethyleneglycol/phos-
phatidyl-ethanolamine conjugates (PEG-
PE) accumulated in the infarction zone with 
efficiency more than 8-fold higher as com-
pared to a non damaged part of the heart 
muscle by EPR effect (Lukyanov et al., 
2004).  
 
CARBON NANOTUBE (CNT) 
A carbon nanotube is like a sheet of 
graphite that is rolled into a cylinder, with 
distinctive hexagonal latticework making 
up the sheet. The carbon nanotubes (CNTs) 
are interesting material because of their size 
range in the nanoscale dimension and their 
wide applicability in the nanotechnology 
and various electronic devices (Frank et al., 
1998; Kong et al., 1999), gas storage media 
(Liu et al., 1999), nanotweezers (Kim et al., 
1999). The high aspect ratio, high conduc-
tivity and intrinsic strength of carbon-
carbon sp2 bond (Ijima, 1991) give them 
highest strength and conductivity compo-
sites to impart unique properties (Wong et 
al., 1997; Ajayan et al., 2000). Since the 
discovery of CNTs, a large number of ef-
forts have been made worldwide to improve 
the preparation and the study of various 
mechanisms used in their formation. There 
are two main types of CNTs that can have 
high structural perfection. Single walled 
nanotubes (SWCNTs), consist of a single 
graphite sheet seamlessly wrapped into a 
cylindrical tube. Whereas multi walled 
nanotubes (MWCNTs), comprise an array 
of nanotubes one concentrically placed in-
side another like rings of a tree trunk (Qian 
et al., 2002). 
 
Synthesis of CNT 
Various methods reported for the for-
mation of carbon nanotubes are arc dis-
charge (Zeng et al., 1998), laser ablation 
(Ma et al., 2000), carbon monoxide dispro-
portionation (Herreyre et al., 1995), chemi-
cal vapor deposition (CVD) (Benito et al., 
1998), Hydrothermal method (Gogotsia et 
al., 2000).  
Arc discharge method 
Arc discharge method is the oldest 
method to synthesize CNTs. CNTs can be 
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synthesized using an arc discharge appa-
ratus made up of stainless steel which is 
first evacuated and then filled with liquid 
N2 or helium gas atmosphere. The pure 
graphite rod is made anode and doped with 
a suitable catalyst like Fe, Co, Ni or bime-
tallic catalyst like Y/Ni. Another graphite 
rod is made cathode. The arc is generated 
by a DC of 40–100 Amperes with maxi-
mum voltage of 50 V in a helium atmos-
phere at a pressure of 100–700 Torr. Under 
these experimental conditions the carbon 
material sublimating at the anode is depos-
ited as a hard crust at the cathode. After the 
arc discharge, the carbonaceous material is 
collected from the cathode regions and 
characterized by SEM, TEM and Raman 
spectroscopy (Ijima, 1991).  
The different sized SWCNT and 
MWCNT can be synthesized by varying the 
critical factors like metal catalyst used, 
range of direct current and voltage supplied 
and the pressure of helium gas or liquid N2 
and temperature gradient between the elec-
trodes used in the experimental conditions. 
Laser ablation method 
In this process a carbon surface general-
ly graphite is irradiated by a laser beam at a 
very high temperature under inert atmos-
phere in a particular reactor and a material 
is removed from the surface. Carbon is va-
porized due to the heat produced by laser 
beam. The SWCNT and MWCNT both can 
be synthesized by this process. The metal 
catalysts are required to be added to the 
graphite target to synthesize SWCNTs. The 
laser beam is targeted on the carbon target 
containing 1.2 % catalyst with 98.8 % of 
graphite composite at 1200 °C in quartz 
tube furnace under the inert atmosphere of 
argon at high pressure of ~500 Torr to pro-
duce SWCNT. The diameter distribution of 
SWCNTs varies about 1.0-1.6 nm produced 
by this method (Guo et al., 1995).  
The quantity, average length and diame-
ter of CNTs depends on the parameters like 
laser wavelength, composition of catalyst 
used, temperature, pressure, type of inert 
gas used. The laser ablation process is 
much better than the arc discharge method. 
The 90 % purity of CNTs with a very nar-
row distribution of diameter can be ob-
tained by laser ablation method. 
CO disproportionation 
Disproportionation reactions are those 
in which a single element is simultaneously 
oxidized and reduced. CO disproportiona-
tion reaction such as 2 CO → C + CO2 pro-
duces only C and CO2 as a product. Since 
CO2 is a stable gas and C is used as a pure 
source to obtain CNT. In this process, fer-
rocene and iron pentacarbonyl were used 
under CO or N2 as a carrier gas at ambient 
pressure. Here CO reacts with iron penta-
carbonyl to form SWCNT at a temperature 
between 1100 °C and 1300 °C with the flow 
direction upward. This process is called 
HiPCO (High pressure carbon monoxide 
reaction) (Moisala et al., 2006).  
In another study the synergistic effect of 
Mo and Co on the catalyst performance for 
CNTs formation was analysed. The pres-
ence of both metals simultaneously at low 
Co: Mo ratio on the silica support was 
found to be effective as the catalyst. The 
extent of the interaction between Co and 
Mo is a function of Co: Mo ratio in the cat-
alyst (Resasco et al., 2002). The characteri-
zation of CNTs was done by SEM, TEM, 
AFM and Raman spectroscopy. 
Chemical vapor deposition (CVD) 
This method is simple and is used for 
CNTs production with controlled growth 
direction on the substrate. The process in-
volves the passing of a mixture of hydro-
carbon gases (methane, ethylene or acety-
lene) through the tubular reactor in which 
the catalysts like Fe, Co, and Ni are depos-
ited on the substrate (usually silica) at a 
temperature of 600 °-1200 °C at atmospher-
ic pressure to decompose the hydrocarbon 
material (Kumar et al., 2010).  
The silica is ideal substrate for growing 
self aligned CNT on large surfaces. The 
CNT formed as a result of thermal decom-
position deposits on the substrate of cata-
lyst. Silica substrate with oxide layer was 
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patterned with UV photolithography. Iron 
(Fe) as a catalyst is electron beam evacuat-
ed on this patterned substrate and ultrasoni-
cated in acetone for 30 min. The substrate is 
then placed on quartz tube and sealed in 
quartz tube CVD furnace at temperature of 
700 °-800 °C using methane, acetylene and 
hydrogen and then characterized (Turano 
and Ready, 2006). 
Hydrothermal method 
This method has many advantages as 
compared to CVD method since it is safe 
for environment, inexpensive, and uses 
lesser free energy for various equilibria. 
The formation of hydrothermal CNT occurs 
at relatively low temperature > 200 °C and 
low pressure 10-100 MPa. A low cost pol-
ymer polyethylene (PE) is used as a carbon 
source and placed in deionized water in Au 
capsule. The amount of water used can vary 
from 0-1.6 times the weight of PE. Ni cata-
lyst is added to the capsule and heated in a 
reactor at a 700°-800 °C for 2-24 h at an ini-
tial pressure of 60-80 MPa and then pres-
sure increased up to 100 MPa of water for a 
sufficient time period so as to allow com-
plete thermal decomposition of PE (Gogot-
sia and Libera, 2000).  
 
Encapsulation of different types of drugs 
on CNTs 
Different kinds of drugs can be encap-
sulated into the hollow structure or inner 
cavities of CNTs to improve their efficacy. 
Folic acid (FA) and PEG was directly ad-
sorbed on to the surface of CNT to make a 
water soluble and cancer cell targeting drug 
delivery system. The drug doxorubicin 
(DOX) was loaded onto the PEG-FA CNT 
surface at 149.3 ± 4.1 % loading efficiency. 
The drug delivery system released DOX at 
reduced pH value particular for the envi-
ronment of cancerous cells and for lyso-
somes / endosomes. The released DOX will 
stop transcription leading to cell death (Niu 
et al., 2013). Paclitaxel (PTX) was conju-
gated to the PEGylated SWCNTs and upon 
conjugation their toxicity level to tumour 
cells was almost similarly as that of taxol 
under in vivo conditions. This has increased 
the blood circulation time of PTX that led 
to increased uptake of the drug by tumour 
cells (Liu et al., 2008). 
The antitumour agent HCPT was cova-
lently conjugated with MWNTs using dia-
minotriethylene glycol. MWNT-HCPT con-
jugated with 16 % drug loading was superi-
or in its anti-tumour activity due to pro-
longed blood circulation time as compared 
to clinical formulations of HCPT. The fast 
release profile of drug HCPT was observed 
at pH = 5.0 than at pH = 7.4 within moni-
toring period of 128 h (Wu et al., 2009). 
Carboplatin, a therapeutic agent for cancer 
treatment was filled into opened CNT by a 
wet chemical method. The effect of this 
drug for cell proliferation and cell cytotoxi-
city was tested on human bladder cancer 
cell line EJ28. The tests have confirmed the 
anti cancer effect of the CNT filled with 
cisplatin (Hampel et al., 2008). 
 
Surface modifications of CNT  
CNTs are sterically bulky, π- conjugat-
ed ligands and electron deficient alkenes. 
SWCNTs can undergo reactions not only at 
the ends and defected sites, but along the 
side walls also. The unique mechanical and 
electronic properties can be changed in a 
determinate way by the controlled chemical 
functionalization (Banerjee et al., 2005). 
The CNTs synthesized by using all the 
above methods generally yield a sample 
that is a mixture of varied diameters and 
chirality of CNTs and often contaminated 
with metallic and amorphous impurities. 
The chemical processing of CNTs is neces-
sary to separate them according to diameter 
and reactivity.  
The interfacial interaction of MWCNTs 
can be improved with the matrix by attach-
ing epoxy functional group to the nanotubes 
(Gojny et al., 2003). To improve the chemi-
cal compatibility of MWCNTs with specific 
polymers for application in nanotube-based 
polymer matrix composites, functionalized 
MWCNTs were silanized using a coupling 
agent, 3-aminopropyltriethoxysilane (3-
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APTES) (Kathi and Rhee, 2008). A versa-
tile method has been developed to selec-
tively attach gold nanoparticles on CNTs 
with various modifications of the nanotubes 
to enhance the potential applications for the 
generation of electrical, optical, and sensor 
devices (Jiang et al., 2003). 
 
Drug loading and release 
There are two ways of drug loading to 
CNTs. In one case, drug molecule is incor-
porated into the nanoparticle at the time of 
formation of nanoformulation. While in 
other case, drug is loaded by adsorption 
method after the synthesis of nanoparticle 
(Singh and Lillard, 2009). Small molecules 
can be loaded by covalent conjugation 
method while other aromatic drug mole-
cules can be loaded onto CNTs by non co-
valent supramolecular chemistry via π-π 
stacking (Liu et al., 2009). The drug release 
from CNTs can be controlled by varying 
the pH value and temperature. 
 
Cellular response 
The nature of the functional groups at-
tached on the surface of CNTs plays a ma-
jor role in deciding the mechanism of inter-
action with the cellular machinery. The 
CNT cellular uptake mechanism may also 
vary depending on the size of the CNTs, in-
cluding endocytosis or passive diffusion. In 
vitro fibroblast response (Zhou et al., 2010) 
demonstrated that MC3T3-E1 cells strongly 
responded to surface nanotopography for 
PVA / halloysite nanotubes (HNTs) bi-
onanocomposite films. The transparent bi-
onanocomposite films favored to fibroblasts 
attachment and growth below 7.5 wt % of 
HNTs incorporated. The mechanism of cel-
lular uptake by HeLa cells is that 
DOX/PEG-FA/SWCNTs firstly attach onto 
cell membrane of HeLa cells by folic acid 
(FA) targeting and enter into the lysosomes 
or endosomes by clathrin-mediated endocy-
tosis. Then DOX is released in the acidic 
environment of lysosomes and migrates in-
to nucleus to inhibit transcription by bind-
ing to DNA and induces cell death (Niu et 
al., 2013).  
 
DENDRIMER 
The dendrimer is a macromolecule 
which is highly branched, monodispersive, 
symmetric and spherical three dimensional 
polymeric molecules having a well defined 
molecular mass. The dendrimer chemistry 
was first discovered by Buhleier et al. 
(1978). In 1985, Tomalia and co-workers 
synthesized the first family of dendrimers. 
Newkome’s group independently reported 
the synthesis of similar macromolecules 
and named them arborols (Newkome et al., 
1985). The term dendrimer originated from 
the Greek word dendron (tree) and meros 
(part). The other synonyms of dendrimer 
are arborols and cascades. But the den-
drimer is most acceptable term worldwide. 
The dendrimers provide a high degree of 
versatility and surface functionality. The 
functionality of these nanostructure den-
drimers can be even improved by encapsu-
lation or the conjugation of bioactive agents 
on the surface of dendrimers (Tomalia and 
Frechet, 2002). The dendrimer consists of 
three architectural components core, 
branches and surface moieties. Due to their 
multivalent and monodisperse character, 
dendrimers have stimulated wide interest in 
the field of chemistry and biology, especial-
ly in applications like drug delivery, gene 
therapy and chemotherapy. 
 
Synthesis of dendrimers 
The synthesis of dendrimer requires the 
selection of a suitable initiator which can be 
transformed into a core. Core reacts with a 
number of molecules in an iterative reaction 
sequence to form new generation of high 
molecular weight and branched dendrimers 
having specific molecular surface. Den-
drimers are produced in iterative sequence 
of reaction steps where addition of each it-
eration produces a higher generation of 
dendrimer (Tomalia and Frechet, 2002). 
The synthesis method used for dendrimer 
preparation permits almost entire control 
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over the critical molecular design parame-
ters such as size, shape, surface / interior 
chemistry, flexibility, and topology. The 
dendrimers can be synthesized by using fol-
lowing three different approaches (Crespo 
et al., 2005). 
Divergent approach 
In this method, dendrimer grows out-
wards from a multifunctional core molecule 
towards periphery. As a result of this 
growth, each new iterative reaction is char-
acterized by the generation of an exponen-
tially increasing number of functional 
groups on the periphery and double the mo-
lecular weight than the previous layer 
(Buhleier et al., 1978). The reaction steps 
can be repeated to increase the size of den-
drimers as required. Many problems occur 
from side reactions and incomplete reac-
tions of the end groups that lead to structur-
al defects. To prevent side reactions and for 
completion of reactions, large amount of 
reagents are required. Therefore, there is 
difficulty in the purification of final product 
prepared through this method (Klajnert and 
Bryszewska, 2001). 
Convergent approach 
The convergent method forms a den-
drimer from outside to inside just opposite 
to that of divergent approach. The den-
drimer formation starts from the peripheral 
end and it progresses towards the core. It 
involves the synthesis of dendrimeric frag-
ments followed by their subsequent addi-
tion to the core. With this method, it is easy 
to change the core group but difficult to 
change the end group. The convergent 
method has some advantages over the di-
vergent method as it does not allow the 
formation of high generation of dendrimers 
due to the problems of steric hindrance be-
tween the reactions of end groups with the 
core molecules (Hawker and Frechet, 
1990). It is relatively easier to purify the 
end product and the defects are minimized 
in the final structure (Crespo et al., 2005; 
Klajnert et al., 2001). 
Double stage convergent approach 
The synthesis of dendrimers by using 
either divergent or convergent approach re-
quires significant number of steps and takes 
a lot of time. To overcome these problems, 
double stage convergent approach is the 
best approach for dendrimers synthesis. The 
double stage convergent approach is a con-
jugation of both divergent and convergent 
approach (Takanashi and Yamamoto, 
2007). In this method, the building blocks 
are synthesized by divergent method fol-
lowed by convergent dendrimer assembly. 
The preparation of higher generation den-
drimers is not tedious as it reduces the 
number of steps for the synthesis and puri-
fication of end product. Moreover, it is easy 
to modify the building blocks during syn-
thesis by divergent method and dendrimer 
assembly with other building blocks to en-
hance diversity (Crespo et al., 2005). 
 
Encapsulation of different drugs on  
dendrimers 
The drug molecules can be covalently 
attached to the periphery of the dendrimer 
to form dendrimer prodrugs. The second 
method is that the drug molecule is 
coordinated to the outer functional groups 
with ionic interactions. The third method 
describes that the dendrimer acts as a 
unimolecular micelle comprising a 
hydrophobic core and a polar surface by 
encapsulating a drug molecule through the 
formation of a dendrimer-drug (host–guest) 
interaction. The encapsulation ability of 
dendrimers increases with the increase in 
dendritic generation and with the increase 
in size and molecular weight of functional 
groups attached (Crampton and Simanek, 
2007).  
Doxorubicin (DOX) was conjugated to 
PAMAM dendrimers through amide or 
hydrazone (hyd). Both ‘light before’ and 
‘light after’ photochemical internalization 
(PCI) strategies were used to improve the 
cytotoxicity of DOX on Ca9-22 cells. It 
was observed that ‘light after’ PCI treat-
ment has enhanced the release of DOX 
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from the DOX-hyd-PAMAM dendrimer 
conjugate as compared to ‘light before’ PCI 
treatment which led to the accumulation of 
DOX in nucleus and caused more cell 
death. But both the PCI strategies were 
failed to improve the cytotoxic effect of 
DOX-amide- PAMAM dendrimer (Lai et 
al., 2007). Paclitaxel was encapsulated into 
the polymeric solution of poly(OEGMA), 
five-arm star poly(OEGMA) and poly-
glycerol dendrimers (dendriPGs). The 
increased paclitaxel solubility was found in 
increasing order of DendriPGs, five arm 
star poly(OMEGA) and poly(OMEGA). 
Paclitaxel release study showed that all the 
paclitaxel was released from the 
dendrimeric solutions after 96h. Under-
standing the solubility mechanism by the 
use of polymers will help to develop better 
delivery system for poorly soluble drugs 
(Ooya et al., 2003). The anti-tumour drugs 
10-hydroxy camptothecin (HCPT) and 7-
butyl-10-aminocamptothecin (BACPT) 
were encapsulated into polyester den-
drimers by solvent evaporation method. A 
20-fold increase in water solubility of 10-
HCPT was observed following encapsu-
lation. The dendrimer encapsulation method 
has increased the drug potency and cell 
specific uptake of camptothecin by the 
human colon cancer cell lines HT29 
(Morgan et al., 2006). 
Flurbiprofen (FB) is a derivative of 
phenylpropionic acid having analgesic and 
anti-inflammatory activity. The drug is 
widely used in the treatment of rheumatoid 
arthritis. The use of PAMAM dendrimers 
for encapsulation and controlled release of 
FB has been reported (Asthana et al., 2005). 
In vivo studies showed the initial fast re-
lease of drug followed by the comparative 
slow release. The dendrimers were able to 
localize the drug at the site of inflammation 
and therefore drug showed its better phar-
macological actions. The PAMAM den-
drimers were also used as drug delivery ve-
hicles to increase the transdermal permea-
tion of idomethacin as the drug is hydro-
phobic and poorly soluble in aqueous me-
dia. The dendrimers act as carrier to 
transport the drug molecules in the skin in 
the solubilised form (Chauhan et al., 2003). 
The drug molecule ibuprofen was 
encapsulated in PAMAM dendrimers 
generated with  3 and 4 –NH2 functionality 
by solvent evaporation method. The 
dendrimers-ibuprofen complex entered in 
the lung epithelial carcinoma cells A549 
rapidly. Pure ibuprofen was found to be 
entered into the cell in 3 hours but the 
dendrimers-ibuprofen complexes were 
entered into the cell in 1hour. So these 
results show that dendrimers can carry drug 
efficiently inside the cell (Kolhe et al., 
2003).  
 
Surface modifications of Dendrimers 
Amine-terminated polyamidoamine 
(PAMAM) dendrimers were surface modi-
fied in a number of ways to reduce the tox-
icity of amine terminus, to increase the bio-
compatibility, to increase water solubility 
of the dendrimers so as to trigger the drug 
carrying efficiency to the target tissue (Kim 
et al., 2008). The ligand conjugated den-
drimers serve for many biomedical applica-
tions as in drug delivery, anti-viral agents, 
development of various artificial proteins. 
The peptide and saccharide-dendrimer con-
jugates were prepared to increase efficacy 
(Chabre and Roy, 2008; Sebestik et al., 
2011). The PAMAM dendrimers were sur-
face modified with polyethylene glycol, L-
arginine (Choi et al., 2004). Jevprasesphant 
et al. (2003) had proved that the PAMAM 
dendrimers modified with lauroyl moieties 
showed the reduced cytotoxicity and in-
creased permeation when interacted with 
Caco-2 cells as compared to unmodified 
dendrimers.  
 
Drug loading and release 
Dendrimers are used as drug delivery 
vehicles bacause of relatively higher 
chemical and biological stability, efficacy, 
purity and long shelf life. The drug 
molecules can be loaded inside dendrimers 
by physical entrapement or chemical 
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conjugation. The drug molecule is released 
inside the cells by two different 
mechanisms. One method includes the in 
vivo break down of covalent bond between 
the drug and dendrimer which can be 
possible in the presence of suitable 
environment or the presence of enzymes. 
The second method for releasing the drug 
depends on changes in pH and temperature 
inside the cells (Mishra, 2011). 
 
Cellular response 
The increase in cellular uptake of drugs 
is dependent on the charge density and flex-
ibility of the dendrimers (Morgan et al., 
2006). The G-4 polypropylenimine den-
drimers increased the cellular uptake of a 
31 nucleotide triplex-forming oligonucleo-
tide (ODN) by 14-fold in MDA-MB-231 
breast cancer cells for delivery in prostate, 
breast and ovarian cancer cell lines as com-
pared with control ODN uptake (Santha-
kumaran et al., 2004). Dendrimers en-
hanced availability and anti proliferative ac-
tivity of intact ODN within cells up to 48 h 
or more. The SWCNT coated with PA-
MAM dendrimers reduced the cytotoxicity 
and improved the cellular uptake by MCF-7 
cancer cell lines. The dendrimer coated 
SWCNT entered the cell cytoplasm by en-
docytosis but the uncoated SWCNT were 
unable to traverse the cell membranes (Pan 
et al., 2007).The dendrimers encapsulated 
with 10-hydroxy camptothecin enhanced 
the cellular uptake by 16 fold and also in-
creased the retention time of the compound 
in cancer cell lines (Morgan et al., 2006). 
 
MAGNETIC NANOPARTICLES 
(MNPS) 
The magnetic nanoparticles (MNPs) are 
of great interest to the scientists from the 
last few decades due to their great magnetic 
properties for the use in various novel ap-
plications ranging from high density data 
storage to biomedical applications. The 
magnetic surface of MNPs allows their at-
tachment to the functional molecules which 
then provide the magnetic behaviour to the 
target (Ahn et al., 2004). It helps to manipu-
late and transport the molecules to the de-
sired target organ by controlling the mag-
netic field produced. Three functional parts 
of a MNP carrier are magnetic core, a sur-
face coat and a functional outer coating 
(Vatta et al., 2006). The magnetic core con-
sists of a supramagnetic molecule whose 
composition depends upon the application. 
The surface coating is required to provide 
steric repulsions, to enhance the stability 
and to prevent agglomeration of the parti-
cles (Charles et al., 1980). The functional 
outer coating may contain any ligand or the 
biologically active molecule for various bi-
omedical applications (Hafeli, 2004). 
 
Synthesis of MNPs 
There are various methods for the 
synthesis of MNPs that include co-
precipitation, thermal decomposition, 
microemulsion, hydrodermal synthesis, 
sonochemical, and sol-gel method. The 
most important technique to synthesize 
supramagnetic NPs is co-precipitation. The 
main challenge to synthesize the 
monodisperse MNPs of suitable size is to 
select the proper experimental conditions. 
Co-precipitation method 
Co-precipitation method generally deals 
with precipitation of substances generally 
soluble under the applied conditions. It is a 
facile and easy method for the synthesis of 
iron oxides (either Fe3O4 or γ-Fe2O3) from 
aqueous Fe2+/Fe3+salt solutions by adding a 
base at room temperature or at elevated 
temperature under inert conditions. Massart 
(1981) first time performed the controlled 
preparation of superparamagnetic iron 
oxide particles using alkaline precipitation 
of FeCl3 and FeCl2. The size, shape and 
composition of the MNPs depend on the 
type of salts used (e.g. chlorides, sulphates, 
nitrates), the ratio of Fe2+/Fe3+, the 
temperature of the reaction, pH and ionic 
strength of the media (Babes et al., 1999). 
The main benefit of this process is that a 
large amount of NPs can be synthesized. 
However, the control of particle size 
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distribution is limited, because only kinetic 
factors can control the growth of the 
crystal.  
Thermal decomposition method 
The MNPs of monodisperse type and 
small size can be synthesized by the ther-
mal decomposition of organometallic pre-
cursors in high boiling solvents that contain 
the stabilizing surfactants. The ratios of 
precursors, surfactants, solvents, reaction 
temperatures, reaction times are significant 
parameters to control the size and shape of 
the synthesised MNPs. The halogen assist-
ed formation of iron oxide nanocrystals was 
done and showed that both Cl- and Br- ions 
work on stabilizing 100 facets of spinal 
structured iron oxide nanocrystals (Xu et 
al., 2010).  
In the literature, a general and very sim-
ple approach to synthesize the size and 
morphology controlled magnetic iron oxide 
nanocrystals is reported. The reaction sys-
tem was based on thermal decomposition of 
the metal fatty acid salts like decanoic acid, 
lauric acid, myristic acid, palmitic acid, ole-
ic acid, stearic acid and a hydrocarbon sol-
vent such as octadecene (ODE), n-eicosane, 
tetracosane or a mixture of ODE and tetra-
cosane. Using this approach, monodisperse 
Fe3O4 nanocrystals in a size range of 3-
50 nm were synthesized. This method can 
also be used to synthesize metallic NPs (Ja-
na et al., 2004). 
Microemulsion 
Microemulsions are clear, thermodyna-
mically stable, isotropic liquid mixtures of 
oil, water and surfactant, and are frequently 
used in combination with a co-surfactant. 
The surfactant molecule lowers the 
interfacial tension between water and oil 
resulting in the formation of a transparent 
solution. There are three basic types of 
microemulsions; direct (oil dispersed in 
water, o/w), reversed (water dispersed in 
oil, w/o) and bicontinuous. The water-in-oil 
(w/o) microemulsion method has been 
widely used to synthesize uniform sized 
MNPs (Liu et al., 2000). The iron oxide 
MNP was synthesized by using sodium 
dodecylbenzenesulfonate (NaDBS) to form 
water-in-toluene reverse micelles. The 
average particle size of single crystalline 
MNPs was in the range of 4 to 15 nm. 
Santra et al. (2001) reported a water-in-
oil microemulsion method for the synthesis 
of uncoated and silica-coated iron oxide 
NPs. Triton X-100, Igepal CO-520, and 
Brij-97 as non-ionic surfactants and 
NH4OH, NaOH as base were used for the 
preparation of microemulsions. Their effect 
on the particle size, crystallinity, and the 
magnetic properties was studied. Micro-
emulsions can be used to synthesize 
monodisperse NPs with different morphol-
ogy. The major disadvantages of this 
method are need of a large amount of 
solvent, low product yield, difficulty in 
scale-up and adverse effects of residual 
surfactants on the properties of MNPs 
(Faraji et al., 2010; Hasany et al., 2012). 
Hydrothermal synthesis 
Hydrothermal processing method for 
the synthesis of MNPs is also called 
solvothermal method. It comprises aqueous 
reactions usually carried out by using 
autoclaves at high pressure over 2000 psi 
and at high temperature of more than 
200 °C. In this process, the reaction 
conditions of precursor material, solvent, 
temperature, pH and time have important 
effect on the product and phase purity of 
the nanoparticles (Chen and Xu, 1998). 
There are two main routes for the formation 
of ferrites via hydrothermal conditions: 
hydrolysis and oxidation and second is 
neutralisation of mixed metal hydroxides.  
The synthesis of nickel ferrite NPs by 
using ethylene glycol as solvent and NaAc 
as electrostatic stabilizer has also been re-
ported. The size of the NPs was easily con-
trolled from 6 to 170 nm by adjusting the 
experimental parameters such as reaction 
duration, initial concentration of the reac-
tants, amount of protective reagents and the 
type of acetates used. The major drawback 
of the conventional hydrothermal method is 
slow reaction kinetics at any given tempera-
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ture. However, this problem may be over-
come by microwave heating (Wang et al., 
2009). 
Sonochemical method 
The sonochemical method is being used 
to generate novel materials with unusual 
properties. Actually, the physiochemical ef-
fects of very high temperature generated 
hot spot by the rapid collapse of sonically 
created cavities allow the conversion of fer-
rous salts into MNPs. The superparamag-
netic iron oxide NPs (SPIO) of high mag-
netization and crystallinity using a sono-
chemical method has been synthesized. The 
coated SPIO were dispersed in chitosan. 
The hydrodynamic diameter of the coated 
SPIO in the chitosan solution was found to 
be 65 nm (Kim et al., 2005).  
Also, nanosized amorphous alloy pow-
ders of Co20Ni80 and Co50Ni50 were pre-
pared by sonochemical decomposition of 
solutions of volatile organic precursors, 
Co(NO)(CO)3 and Ni(CO)4  in decalin, un-
der an argon pressure of 100 to 150 kPa at 
273 K. Magnetic measurements have indi-
cated that the prepared amorphous CoNi al-
loy particles were superparamagnetic (Shafi 
et al., 1998).  
Sol-gel method 
The sol-gel process is based on the hy-
droxylation and condensation of molecular 
precursors like metal alkoxides in solution 
forming a “sol” of nanometric particles. 
The ‘‘sol’’ is then dried or termed as 
‘‘gelled’’ by solvent removal or by chemi-
cal reaction to 3-D metal oxide network 
(Ismail, 2005). The crucial factors like sol-
vent, temperature, nature and concentration 
of the salt precursors employed, catalyst, 
additives, pH, and agitation affect on kinet-
ics, growth reactions, hydrolysis, condensa-
tion reactions and the structure and proper-
ties of the gel (Hasany et al., 2012).  
Sol-gel method has been used to prepare 
a series of Fe2O3-SiO2 nanocomposites (9-
33 % Fe2O3 by wt) and submitted to thermal 
treatments in the temperature range of 
300 °C - 900 °C. Synthesised nanocompo-
sites were further characterized by XRD, 
TEM, EPR and magnetic susceptibility 
measurements (Cannas et al., 1998). A 
high-purity La2/3Ca1/3MnO3 perovskite has 
also been produced via a simple sol-gel 
process by dissolving the appropriate inor-
ganic salts in ethanol-acetic acid mixture 
without using any complexing agents (e.g., 
polyol or polyhydroxy acid, etc.) which is 
otherwise essentially used in the polymeric 
precursor routes (Mathur and Shen, 2002). 
 
Encapsulation of different drugs inside 
MNPs 
Various kinds of drugs have been en-
capsulated in MNPs for targeted delivery. 
The therapeutic drug molecules are either 
attached to the surface of MNPs or encap-
sulated within a nanocomposite mixture of 
a polymer and MNPs (Mody et al., 2013). 
The presence of various polymer or met-
al/non metal coating on the surface of 
MNPs provides better opportunity to attach 
various drugs for targeted delivery.  
Under this category, DOX has been de-
livered to target tumour sites using G2, G3, 
G4, and G7 PAMAM dendrimer MNPs 
(DcMNPs). The maximum drug loading 
concentration was 400 µg/mL. Interesting-
ly, G4DcMNPs were found to be the most 
efficient drug delivery systems (Rouhollah 
et al., 2013). The anti tumour agent, 
paclitaxel was covalently conjugated to sili-
ca coated magnetic NPs (TXL-SiMNP). To 
check the anti tumour activity, in vitro 
evaluations of developed SiMNP-TXL and 
SiMNP as a control formulations of various 
concentrations was performed on human 
breast adenocarcinoma cells (MDA-MB-
468 triple-negative) upto 5 days. The TXL 
loaded SiMNP formulations were reported 
cytotoxic against the tumour cells in a con-
centration dependent manner (Auzenne et 
al., 2013). 
5-FU was encapsulated in magnet-
ite / PLGA NPs for the magnetically con-
trolled delivery of 5-FU to the cancer cells. 
The encapsulation efficiency of MNPs was 
60 - 80 %. The in vitro release profiles of 5-
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FU has indicated the initial fast release fol-
lowed by a 7 day lag period. This has signi-
fied the potential viability of the magnet-
ite / PLGA nanomaterials for effective drug 
delivery (Ashjari et al., 2012). Curcumin is 
a major polyphenolic pigment found in 
turmeric root, possessed antitumor and an-
tioxidant activities. However, the efficacy 
and bioavailability of as such curcumin is 
very poor. Therefore, curcumin was encap-
sulated in a polymeric MNP that was syn-
thesized by cross linking of polymers β-
cyclodextrin with epichlorhydrin and mag-
netite as magnetic material. The in-vitro re-
lease of curcumin loaded MNPs showed in-
itial release for first 24 hours followed by 
slow release up to 96 hours (Silambarasi et 
al., 2012). 
Methotrexate (MTX), an anticancer 
drug was covalently bound with iron oxide 
supramagnetic NPs for targeted drug deliv-
ery to cancer cells having overexpressed fo-
late receptors on the surface (Kohler et al., 
2005). Treatment of developed MTX nano-
composite on MCF-7 and HeLa cells has 
shown their internalization at a high level 
into lysosome. Here in lysosome, MTX was 
released at low pH by enzymatic cleavage 
of peptide bond. These studies have docu-
mented that MNPs can be used as smart 
carrier for controlled and targeted drug de-
livery  
 
Surface modification of MNPs 
The MNPs are very sensitive to ag-
glomeration and oxidation reactions due to 
their large surface area, and high magnetic 
dipole interaction. It is often desirable to 
protect the surface of MNPs with the use of 
stabilizers to reduce oxidation reactions and 
aggregation due to magnetic and electrical 
interactions. In addition, surface modifica-
tions also enhance the stability of MNPs 
enabling them more biocompatible. It al-
lows for further functionalization of the na-
noparticle surface to provide additional 
functionality to the magnetic core (Wil-
liams and Corr, 2013). Therefore, the sur-
face of MNPs can be easily functionalized 
by coatings of polymers, silica, carbon, and 
metal. 
The stability has been shown to be im-
proved in biological media by the surface 
coating of MNPs with gum Arabic (GA). 
The GA-treated NPs were forming smaller 
agglomerates as compared to the untreated 
samples over 30h time period (Williams et 
al., 2006). The silica coated surface of 
MNPs was modified with (aminopropyl)-
triethoxysilane (APTS) to enhance their po-
tential in research and diagnostic applica-
tions (Bruce and Sen, 2005). The supra-
magnetic NPs were surface modified with 
PEG to increase their biocompatibility and 
cellular uptake. Such PEGylated NPs influ-
ence have been studied on human fibroblast 
cells (Gupta and Curtis, 2004).  
 
Drug loading and release 
MNPs serve as an efficient drug deliv-
ery system and therefore, offering a flexible 
drug loading and sustained therapeutic re-
lease of drug under the influence of external 
magnetic field. A drug molecule can be 
loaded into MNPs through different meth-
ods, including covalent binding, electrostat-
ic interactions, adsorption or encapsulation 
within the pores of magnetic carrier (Mody 
et al., 2013). The encapsulation of drug in-
side MNPs is confirmed by UV-Vis spec-
troscopy, FTIR, and HPLC. Drug-loaded 
magnetic particles reach to the target site by 
active and passive mechanisms. Active 
mechanism is based on the MNP attach-
ment to the ligands and attraction of these 
conjugates to the target-site proteins. Pas-
sive mechanism is based on the enhanced 
permeability retention effect (EPR) inside 
the blood vessels and target cells (Arruebo 
et al., 2007). 
 
Cellular response 
The MNPs are used as drug delivery 
system for tissue/cell specific delivery. The 
cellular response of a particular cell type for 
a drug is possible by coating the surface of 
MNPs with the suitable ligands that can 
bind to the receptors of the target organs 
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(Kim et al., 2006). The biotin conjugated 
lipid coated MNPs were surface functional-
ized by streptavidin fluorescein isothiocya-
nate (FITC) had shown uptake by HeLa 
cells and found to be localized in the lyso-
somal compartment by receptor mediated 
endocytosis (Becker et al., 2007). The up-
take of silica coated MNPs containing rho-
damine B isothiocyanate (RITC) into A549 
human lung cancer cells is temperature de-
pendent and occurs through energy depend-
ent endocytosis by endosomes. The meta-
bolic inhibitors and low temperature of 4 
degrees have inhibited the cellular uptake 
of MNPs (Kim et al., 2006). The cellular 
uptake and cytotoxicity of pullulan coated 
MNPs as compared to uncoated MNPs 
were also investigated. The coated MNPs 
have reduced human fibroblast cell cytotox-
icity and enhanced the cellular uptake by 
different routes distinct from the uncoated 
MNPs (Gupta and Gupta, 2005). Rodriguez 
et al. (2013) had coated carboxymethyl inu-
lin on the surface of iron oxide NPs and 
tested their cytotoxicity towards various 
cancer cell lines. They observed satisfacto-
ry cellular uptake of coated MNPs by Caco-
2 cell lines in a time and concentration de-
pendent fashion. 
 
CONCLUSIONS 
NCs are important candidates for deliv-
ery of therapeutic agents important for 
pharmaceutical industry. They have ad-
vantages over conventional carriers. They 
can improve the efficacy and bioavailability 
of many therapeutic agents which are oth-
erwise difficult to deliver. NCs will in-
crease the half life and persistence of many 
therapeutic agents thus increasing their 
therapeutic index. Surface modified NCs 
with hydrophilic polymers or ligands will 
increase the targeting ability and specificity 
of many therapeutic agents. Surface modi-
fication of NCs offers way for increasing 
cellular uptake and binding. Coupling of 
small molecules on the surface of NCs also 
increases cellular uptake and interaction. 
By smartly designing NCs many therapeu-
tic agents will enter into clinical trials. Cur-
rent research is focussed on encapsulation, 
and targeted delivery of therapeutic agents. 
But more extensive studies are needed to 
establish cellular interactions and fate of 
therapeutic agent loaded NCs. 
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